Abstract:Abstract Introduction Diabetic kidney disease (DKD) is a major microvascular complication of diabetes mellitus (DM) and the primary cause of end-stage renal disease. Routine medication might result in adverse effects which limit their usage. Laboratory studies have shown that Xiao Zheng San Jie (XZSJ) granules is effective in reducing the levels of urinary protein and blood creatinine in rats with DKD. Hence, we aim to conduct a clinical trial to determine the efficacy and safety of XZSJ granules among patients with DKD Stage IV, who present with the syndromes of qi deficiency and blood stasis. The purpose of this paper is to report the methodology of this trial. Methods and analysis This is a randomised, double-blind, placebo-controlled, multi-centre clinical trial. A total of 72 patients with DKD Stage IV who have the syndromes of qi deficiency and blood stasis will be randomly assigned to either intervention or placebo group. In addition to routine medication, the intervention group will be given XZSJ formula (in granules) and the control group will be given placebo for 12-weeks. Data collected at baseline as well as weeks 4, 8 and 12 will be recorded in case report forms and subsequently entered into EpiData 3.1 electronic database. Adverse events will also be documented. Primary outcomes – estimated glomerular filtration rate, urinary albumin-to-creatinine ratio, and serum creatinine – will be assessed after 12 weeks. Ethics and dissemination This trial has been approved by the Research Ethics Committee of Dongzhimen Hospital (DZMEC-KY-2018-60). Informed consent will be obtained from all participants. Results of this study will be disseminated to the public through academic conferences and peer-reviewed journals. Discussion This trial might provide information on an effective method for the treatment of DKD, especially for patients who present with the syndromes of qi deficiency and blood stasis. We hope that this trial will serve as a reference for the conception of high-quality Traditional Chinese Medicine trials in the future, which incorporate syndrome diagnosis into the study design. Trial registration Chinese Clinical Trial Registry, ChiCTR1900021391. Registered 18 February 2018, http://www.chictr.org.cn/showproj.aspx?proj=36106.

Clinical Study of Treating Blood Stasis of Kidney Fibrosis with Dahuang Zhechong Wan

Curative Effect Observation of Blood Stasis Type LDH by Acupuncture with Plum Needle Stab Heavy Knock Cupping Bloodletting Therapy

Study on clinical effect of Yiqi Yangyin and Huoxue Prescription imposed on fatty liver in type 2 diabetes mellitus

Therapies of Warming Kidney and Draining Dampness, and Activating Blood Circulation and Descending Turbid Used in 187 Cases of Chronic Renal Failure

Clinical Study on Treatment of Chronic Renal Insufficiency Based on Sputum and Blood Stasis Theory

Clinical Observation in the Treatment of Chronic Renal Failure with Jianpi Bushen Xiezhu Method and Colon Dialysis

The Effect of Warming Yang,Benefiting Qi,Improving Blood Circulation and Eliminating Water Methods on BNP Level of patients with Chronic Heart Failure

Experimental Study about Dynamic Changes of Related Growth Factors in Renal Fibrosis and Influence of Traditional Chinese Medicine Can Clear Heat- Dampness Away

Prospective Study on Effect of Stent Placement in Patients with Arteriosclerotic Renal Artery Stenosis on Renal Insufficiency

Clinical Research on Treatment of Early Diabetic Nephropathy by Replenishing Qi and Nourishing Yin,Activating Blood and Dredging Collaterals

Clinical effect of Dahuang Zhechong capsules combined with entecavir in treatment of chronic hepatitis B patients with liver fibrosis

Renoprotective effect of Zhenwu decoction against renal fibrosis by regulation of oxidative damage and energy metabolism disorder

Treatment of Early Diabetic Nephropathy by Therapy of Supplementing Qi, Nurishing Yin, Removing Phlegm and Activating Blood Circulation: A Clinical Observation of 20 Cases

Xiao Zheng San Jie Granules in the Treatment of Qi Deficiency and Blood Stasis Syndrome in Patients With Diabetic Kidney Disease Stage IV: Protocol for a Randomised, Double-blind, Placebo-controlled, Multi-centre Trial

[Clinical study on tangweikang capsule in treating diabetic nephropathy]

Clinical Research on Treating Chronic Prostatitis from Blood Stasis and Blood Turbid Aspect in Different Treatment Stages

Clinical Study on Oral Administration of "ruanjian Huayu Decoction" with External Application of "jiedu Xiaopi Powder" in Treating Early HBV-related Cirrhosis of Blood-Stasis Obstruction

Clinical Observation of "qinggan Huayu Decoction" in Treating Hepatic Fibrosis Following Nonalcoholic Fatty Liver Diseases

EFFECTS OF SINITANG ON HISTOPATHOLOGIC CHANGES OF KIDNEY,HEART AND BRAIN IN RENAL HYPERTENSIVE RAT

Clinical Research on the Role of Point Geshu in Activating Blood and Removing Stasis

Investigation on the Effect of Hemodialysis Combined with MDT Multimode Intervention on Renal Fibrosis Degree and Renal Function Improvement in Uremia Patients